There is clearly something wrong with pharmaceutical innovation.
Antibiotic-resistant infections sicken more than two million Americans every year and kill at least 23,000. The World Health Organization has warned that a “post-antibiotic era” may be upon us, when “common infections and minor injuries can kill.” Even the world’s tycoons consider the proliferation of antibiotic-resistant bacteria one of the crucial global risks of our times, according to a survey by the World Economic Forum.
Yet the enthusiasm of the pharmaceutical industry for developing drugs to combat such a potential disaster might be best characterized as a big collective “meh.”
And this is hardly the drug industry’s only problem. Antibiotics, Professor Kinch told me, “are the canary in the coal mine.”
Read more . . .
The Latest on: Pharmaceutical innovation
[google_news title=”” keyword=”Pharmaceutical innovation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pharmaceutical innovation
- Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcripton May 9, 2024 at 8:37 am
May 8, 2024 Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51. Teva Pharmaceutical Industries Limited isn’t one of the 30 ...
- Royalty Pharma Reports First Quarter 2024 Resultson May 9, 2024 at 5:21 am
Royalty Receipts growth of 14% driving Portfolio Receipts of $717 millionNet cash provided by operating activities of $665 millionFull year 2024 ...
- Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimabon May 9, 2024 at 5:00 am
Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated ...
- Regulatory Challenges In Drug Approval: Balancing Innovation And Patient Safetyon May 8, 2024 at 5:43 am
Navigating the complex landscape of drug approval presents significant regulatory challenges, requiring a delicate balance between fostering pharmaceutical innovation and ensuring patient safety. The ...
- Irish pharma sector quizzes European election candidates on innovation, sustainability, and regulationon May 7, 2024 at 10:17 pm
Irish candidates for the upcoming European parliament elections are attending a series of health manifesto events where pharmaceutical industry experts, the press and the public are quizzing ...
- Astellas Pharma plans to tap collaborations to fill new West Coast Innovation Centeron May 7, 2024 at 5:00 pm
The new Astellas Innovation Center at 480 Forbes Blvd. in South San Francisco Listen to this article 4 min The company built a Bay Area beachhead by buying two biotech companies with cutting-edge ...
- Unlocking Australia’s Beauty Potential: The Rise of Cosmetic and Pharmaceutical Distributionon May 6, 2024 at 10:46 am
Introduction Australia, renowned for its stunning landscapes and diverse wildlife, is also making waves in the beauty and healthcare industry. As the demand for cosmetic and pharmaceutical products ...
- Pharma R&D productivity seen improving for the first time in years - Deloitteon May 4, 2024 at 12:30 pm
While the return on R&D investment from biopharma companies has been a disappointment since 2010 -- with a notable exception in 2020 and 2021 due to COVID-19 -- productivity appears to have turned a ...
- Survey Finds Key Barriers to Pharmaceutical Innovationon May 3, 2024 at 11:43 am
The International Society for Pharmaceutical Engineering recently surveyed nearly 400 pharmaceutical professionals in order to uncover and address the barriers to pharmaceutical innovation. They weigh ...
- ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferenceson May 1, 2024 at 9:30 am
ANI Pharmaceuticals, Inc. (Nasdaq ... leveraging its U.S. based manufacturing footprint, and delivering innovation in Established Brands. For more information, please visit our website ...
via Bing News